Last tested: 2026-05-01 — Edited by Max Yao
Culturelle Digestive Daily Review 2025: The Most Studied Probiotic Strain
Disclaimer: This content is for informational purposes only and is not medical advice. Consult a healthcare professional before starting any supplement. Individual results vary. Some links on this page may earn us a commission at no extra cost to you.
IBS management, AAD prevention, antibiotic recovery
Want multi-strain diversity or a prebiotic included
$19.99/mo
Why One Strain Beats a 50-Strain Blend
Culturelle Digestive Daily contains a single strain: Lactobacillus rhamnosus GG (LGG), at 10B CFU per capsule. That is 10 times fewer bacteria than many competitors. It is also, by a significant margin, the most clinically validated probiotic strain for human gut health.
The LGG Evidence Base
LGG has been studied in over 300 clinical trials. Key findings relevant to a consumer buyer:
Antibiotic-associated diarrhoea (AAD): A 2015 meta-analysis (Szajewska et al, Aliment Pharmacol Ther, PMID 25898944) pooled data from 12 RCTs and found LGG reduced AAD risk by approximately 33% in adults and children. This is a robust, replicated finding.
IBS symptom reduction: Some evidence suggests LGG may modestly reduce bloating and abdominal pain in IBS, though effect sizes are smaller than for AAD. A 2012 systematic review in Alimentary Pharmacology and Therapeutics found mixed results across IBS subtypes — LGG appears more effective for IBS-D than IBS-C.
Traveller’s diarrhoea: Some evidence suggests LGG may reduce risk of traveller’s diarrhoea, though a 2017 Cochrane review noted the evidence is limited (McFarland, Cochrane Database Syst Rev 2017).
What LGG Does Not Do
LGG evidence is specific to LGG. Results from LGG studies do not apply to other Lactobacillus rhamnosus strains, and do not apply to other Lactobacillus species. A product containing “Lactobacillus blend” is not equivalent to Culturelle LGG.
Pros
- ✓ Most studied probiotic strain in human clinical trials
- ✓ Strong AAD prevention evidence (replicated across multiple meta-analyses)
- ✓ Widely available, affordable ($19.99/mo)
- ✓ Shelf-stable — no refrigeration needed
- ✓ Single strain means the full 10B CFU dose delivers the studied strain, not a diluted blend
Cons
- ✗ Single strain — limited microbiome diversity
- ✗ No prebiotic included
- ✗ LGG evidence for IBS-D is moderate, not definitive
- ✗ Not suitable if looking for broad-spectrum microbiome support
Bottom Line
If you are recovering from antibiotics, managing IBS-D symptoms, or travelling to a region with food hygiene concerns, Culturelle is one of the best-evidenced products you can buy for under $20/month. The single-strain approach is a feature, not a limitation — it is why the dose is clinically meaningful.
Note: probiotic effects are strain-specific. A study on LGG does not apply to other Lactobacillus strains.